“…The exact mechanism of cutaneous atrophy following injected CS is not fully understood but is likely due to several factors, most importantly decreased type I collagen and glycosaminoglycan synthesis 10 . Several investigators have examined the histology of local cutaneous atrophy 8,11–13 .…”
Section: Discussionmentioning
confidence: 99%
“…Other significant findings include homogenization of collagen, degeneration of sebaceous glands, decreased elastin, epidermal atrophy, involution of subcutaneous fat lobules, and the presence of CS crystals on polarized microscopy 8,12–14 . Iuel and Kryger reported a case of persistent local cutaneous atrophy following a series of injections of prednisolone tert‐butyl acetate to the metatarsophalangeal joint of the right great toe 10 . Histologic examination 2 years after injection revealed crystals presumed to be CS in the area of atrophy.…”
“…The exact mechanism of cutaneous atrophy following injected CS is not fully understood but is likely due to several factors, most importantly decreased type I collagen and glycosaminoglycan synthesis 10 . Several investigators have examined the histology of local cutaneous atrophy 8,11–13 .…”
Section: Discussionmentioning
confidence: 99%
“…Other significant findings include homogenization of collagen, degeneration of sebaceous glands, decreased elastin, epidermal atrophy, involution of subcutaneous fat lobules, and the presence of CS crystals on polarized microscopy 8,12–14 . Iuel and Kryger reported a case of persistent local cutaneous atrophy following a series of injections of prednisolone tert‐butyl acetate to the metatarsophalangeal joint of the right great toe 10 . Histologic examination 2 years after injection revealed crystals presumed to be CS in the area of atrophy.…”
“…There is no specific treatment for this condition. The injected steroid can be found at the site of injection for a considerable period of time 10 and will maintain the atrophy for this period of time. As in other cases of steroid‐induced atrophy the process is, however, reversible over a period of months 8…”
Two cases of perilymphatic atrophy following correctly administered intralesional steroid injections are reported. Perilymphatic atrophy produces a distinct clinical picture and may persist for months. A review of the literature shows that no treatment is indicated. It is stressed that the appearance of this cosmetically disturbing side effect is unpredictable, but spontaneously reversible.
“…The mechanisms underlying skin changes are not well elucidated, but several authors (51-54) attribute direct cytotoxicity, altered ground substance, vasoconstriction, and/or the mechanical effects of edema as potential underlying reasons. In addition, decreased type I collagen and glycosaminoglycan synthesis are important factors (55).…”
Corticosteroids and local anesthetics are some of the most commonly administered medications in radiology departments. These medications have marked variability in their formulations, which may increase their adverse event profile for specific procedures. In particular, certain corticosteroid preparations are associated with adverse central nervous system (CNS) sequelae. This is most likely due to distal embolization by particulate formulations. Nonparticulate steroid formulations are not associated with such events. Local anesthetics have severe CNS and cardiac adverse effects if injected intravascularly and have recently been associated with intraarticular chondrolysis if used in large doses. This review discusses these medications with particular emphasis on their established and postulated adverse effects. The administering radiologist should be aware of these potential effects and how best to reduce their occurrence.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.